What is Adaptive Biotechnologies Corporation's Shariah compliance score?

Adaptive Biotechnologies Corporation (ADPT) has a Shariah compliance score of 70/100 (Grade: B+, Good) based on AAOIFI screening standards. Scores above 70 typically indicate strong compliance. The score factors in business activity screening and financial ratio analysis including debt levels, interest-bearing deposits, and prohibited income percentages. View the full breakdown at HalalScreener.app.

Does Adaptive Biotechnologies Corporation pass AAOIFI screening?

Adaptive Biotechnologies Corporation (ADPT) partially passes with caution AAOIFI Shariah screening. AAOIFI requires: (1) no primary involvement in prohibited activities like alcohol, gambling, or conventional banking, (2) debt-to-market-cap below 30% (ADPT: 3.6%), (3) interest-bearing deposits below 30% (ADPT: 5.9%), and (4) prohibited income below 5% (ADPT: 4.5%). HalalScreener provides free AAOIFI screening for 10,000+ stocks at halalscreener.app.

How much purification is needed for Adaptive Biotechnologies Corporation stock?

Adaptive Biotechnologies Corporation (ADPT) has a non-permissible income ratio of 4.50%. Muslim investors should purify this percentage of any dividends received and capital gains realized from ADPT shares by donating it to charity. HalalScreener's purification calculator at halalscreener.app/en/purification automates this calculation using the latest financial data.

Where can I screen Adaptive Biotechnologies Corporation for Shariah compliance for free?

HalalScreener (halalscreener.app) offers free Shariah compliance screening for Adaptive Biotechnologies Corporation (ADPT) and 10,000+ other US-listed stocks, ETFs, and 100+ cryptocurrencies. The screening uses AAOIFI Standard No. 21 and shows all financial ratios transparently. No credit card or signup required for basic screening. HalalScreener also includes an AI Islamic Scholar for follow-up questions about ADPT's compliance across different madhabs (Hanafi, Shafi'i, Maliki, Hanbali, Ja'fari).

ADPT: Is Adaptive Biotechnologies Corporation Halal?

Adaptive Biotechnologies Corporation

NASDAQHealthcareUS

$15.14

-0.59%

Market Cap: 2.4B

Compliance Status

Doubtful

Screened on Jul 17, 2026 · AAOIFI Standard 21

B+

Good

70Score

Is Adaptive Biotechnologies Corporation (ADPT) halal? Doubtful. Based on AAOIFI screening, Adaptive Biotechnologies Corporation passes the business activity screen but has financial ratios approaching AAOIFI limits with a compliance score of 70/100 (Grade: B+).

AvoidBorderlineClean

Business activity

What the company sells is permissible.

Passed

Company debt

Well clear of the limit

How much the company borrows, compared to its total value. AAOIFI allows up to 30%.

3.6% of 30.0% limit

What this means for you

You may own ADPT, with caution

Its numbers sit close to AAOIFI limits. Cautious investors may prefer alternatives or ask a scholar first.

Purify 4.5% of your income from ADPT

That is about $4.50 of every $100 you earn from it. Donate this share to charity.

Calculate my exact amount

About Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signals; and T-Detect COVID for the confirmation of past COVID-19 infection. It also provides clonoSEQ, a clinical diagnostic product for the detection and monitoring of minimal residual disease in patients with multiple myeloma, B cell acute lymphoblastic leukemia, and chronic lymphocytic leukemia, as well as available as a CLIA-validated laboratory developed test for patients with other lymphoid cancers; and immunoSEQ T-MAP COVID for vaccine developers and researchers to measure the T-cell immune response to vaccines. In addition, the company offers a pipeline of clinical products and services that are used for the diagnosing, monitoring, and treatment of diseases, such as cancer, autoimmune conditions, and infectious diseases. It serves the life sciences research, clinical diagnostics, and drug discovery applications. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.

Sector: Healthcare · Industry: Biotechnology

Why This Stock Is Doubtful

Non-compliant income is 4.5% of revenue, only 0.5 points below the 5% limit

Stocks are marked Doubtful when financial ratios pass but approach AAOIFI thresholds. Consider consulting a qualified scholar for a definitive ruling.

Shariah Compliance Status

AAOIFI Standard 21Updated Jul 17, 2026

Compliance History

Doubtfulnow
since Jun 2026
Not Halal
until the change above
Halal
until the change above
Not Halal
until the change above

Tracked since May 2026. Updates automatically on each re-screen.

Fiscal: Q1 2026Data source: EDGAR

More Healthcare Stocks

JNJ

Johnson & Johnson

UNH

UnitedHealth Group Incorporated

B+

ABBV

AbbVie Inc.

PFE

Pfizer Inc.

LLY

Eli Lilly and Company

A+

MRK

Merck & Co., Inc.

B+

Free · No credit card required

Track ADPT and 10,000+ stocks with AI insights

Create your free account to unlock AI-powered compliance analysis, track your portfolio, calculate purification, and get unlimited AAOIFI screening.

Get Started Free Browse Screener

10,000+ assets AAOIFI standards Free watchlist

Frequently Asked Questions

Is Adaptive Biotechnologies Corporation (ADPT) halal to invest in?

Adaptive Biotechnologies Corporation (ADPT) is rated Doubtful under AAOIFI Standard 21. It passes the business activity screen but one or more financial ratios are approaching (though not yet exceeding) the AAOIFI thresholds (30% for debt and interest deposits, 5% for prohibited income). Consult a qualified Islamic finance scholar for a personal ruling.

Why did Adaptive Biotechnologies Corporation get a B+ compliance rating?

Adaptive Biotechnologies Corporation (ADPT) received a grade of B+ (Good) based on three AAOIFI Standard 21 financial ratios: debt-to-market-cap of 3.6% (limit 30%); interest-bearing deposits of 5.9% (limit 30%); prohibited income of 4.50% (limit 5%). The grade reflects the margin of safety across all three ratios relative to their thresholds.

What could change Adaptive Biotechnologies Corporation's Shariah verdict?

Adaptive Biotechnologies Corporation's verdict is re-evaluated at each annual re-screen. Three events could change it: (1) the debt-to-market-cap ratio crossing 30%, typically from new debt issuance or a major drop in share price; (2) interest-bearing deposits exceeding 30% of market cap; or (3) prohibited revenue (alcohol, gambling, conventional finance, etc.) exceeding 5% of total revenue. Verdict flips are tracked in the compliance history section above.

How often is Adaptive Biotechnologies Corporation re-screened for Shariah compliance?

Adaptive Biotechnologies Corporation (ADPT) is re-screened annually using the most recent full-year financial data from SEC filings. HalalScreener also triggers an on-demand re-screen whenever the stored data is more than 7 days old, ensuring the ratios reflect the latest available financial statements. Last screened: Jul 17, 2026.

Screened according to AAOIFI Standard No. 21 · For informational purposes only. Consult a qualified Islamic finance advisor before investing.

Disclaimer: This screening is for informational purposes only and does not constitute financial, legal, or religious advice. Compliance is evaluated using AAOIFI financial standards (debt, deposits, and prohibited income ratios) and publicly available data. Ethical, political, social, or environmental considerations are outside the scope of this screening. Individual scholars and methodologies may differ. Always consult a qualified Islamic finance advisor before making investment decisions.